Hiromitsu Tsuchihashi

Osaka University of Pharmaceutical Sciences

Papers

1

Total Citations

2

H-Index

1

About

Hiromitsu Tsuchihashi is a leading figure in gynecologic oncology, with a focused research program on improving surgical outcomes for patients with early-stage cervical cancer. His work centers on refining minimally invasive surgical techniques and advancing the role of sentinel lymph node biopsy (SNB)—a procedure that identifies the first lymph node to receive drainage from a primary tumor. In his landmark 2024 study, Tsuchihashi compared oncologic outcomes between patients undergoing minimally invasive radical hysterectomy with SNB and those receiving traditional lymphadenectomy. This work, already garnering 2 citations, is critical for establishing the safety and efficacy of a less invasive approach that reduces surgical morbidity without compromising cancer control. By providing the first dedicated report on oncologic outcomes after SNB in cervical cancer, Tsuchihashi’s research directly addresses a key knowledge gap and offers a potential new standard of care. His contributions are shaping the future of surgical oncology, offering hope for better quality of life for women facing this diagnosis.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Oncologic Outcomes of Patients with Early-Stage Cervical Cancer after Minimally Invasive Radical Hysterectomy and Sentinel Lymph Node Biopsy
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Osaka University of Pharmaceutical Sciences

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago